我们应用卡博平治疗 60例 2型糖尿病患者 ,观察其治疗前后的空腹血糖、餐后 2小时血糖、HbA1c、甘油三酯、总胆固醇水平 ,疗程为 8周 ,并且观察其副作用的发生情况。结果 :卡博平治疗后患者的空腹血糖、餐后 2小时血糖、HbA1c、甘油三酯、总胆固醇水平均明显低于治疗前 ,且患者腹胀、肛门排气等副作用的发生几率小。结论 ,卡博平能显著地降低 2型糖尿病患者的血糖和血脂水平 ,是一种安全有效的降糖药物。 We use carbopol in the treatment of 60 patients with type 2 diabetes, observed before and after treatment of fasting blood glucose, 2-hour postprandial blood glucose, HbA1c, triglycerides, total cholesterol levels for 8 weeks, and observed the incidence of side effects. Results: The fasting blood glucose, 2-hour postprandial blood glucose, HbA1c, triglyceride and total cholesterol in patients after carbopol treatment were significantly lower than those before treatment, and the incidence of side effects such as abdominal distension and anal exhaust was small. Conclusions: Carbopol can significantly reduce the level of blood glucose and blood lipid in type 2 diabetic patients and is a safe and effective hypoglycemic drug.